Related Experiment Video
Updated: Aug 9, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: November 1, 2010
Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response
1*Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center †Department of Medicine, Division of Clinical Decision Making, Tufts Medical Center, Boston, MA.
Medical Care
|October 14, 2017
Summary
Making health economic analysis source code publicly available enhances credibility and value. Open publication ensures transparency, reproducibility, and innovation, outweighing concerns about intellectual property and misuse.
Area of Science:
- Health Economics
- Computational Science
- Scientific Publishing
Background:
- Health economic analyses increasingly rely on complex computer models.
- Lack of source code transparency hinders independent verification and reproducibility.
- Existing practices in other scientific fields advocate for open computational models.
Purpose of the Study:
- To advocate for the open publication of computer model source code in health economic analyses.
- To address and refute common arguments against source code transparency.
- To highlight the benefits of open publication for scientific credibility and utility.
Main Methods:
- Argumentative and critical review of current practices in health economics.
- Analysis of intellectual property and model misuse concerns related to open source code.
- Discussion of ancillary benefits of open publication, including adaptation and innovation.
Main Results:
- Open publication of source code is essential for assessing alternative assumptions and ensuring reproducibility.
- Concerns regarding intellectual property rights are minimal, and open publication can increase model value.
- Transparency through open source code reduces the risk of model misuse and facilitates evaluation.
Conclusions:
- Open publication of health economic model source code is crucial for scientific integrity and enhancing model utility.
- The benefits of increased credibility, transparency, and innovation outweigh potential challenges and harms.
- Adoption of open publication practices will advance health economics, supporting better health policy and clinical decisions.
Related Concept Videos
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).